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Abstract
 .Alveolar epithelial type 2 T2 cells isolated from the lungs of adult rats responded to exogenous atrial natriuretic peptide
 .ANP by two signalling mechanisms. First, ANP induced a dose-dependent reduction of ligand-stimulated adenylyl cyclase
activity and cAMP accumulation. This effect was inhibited by the addition of GDPb S or by pretreatment with pertussis
 .  . w32 xtoxin PT , consistent with mediation by a Gi protein s . PT-catalyzed P ADP-ribosylation, immunoblots with specific
antisera, and Northern blot analysis demonstrated that T2 cells contain the G-proteins Gi and Gi which could transduce2 3
this signal. ANP also promoted PT-insensitive, dose-dependent accumulation of cGMP, consistent with activation of a
receptor guanylyl cyclase. Isoproterenol-stimulated phosphatidylcholine secretion was markedly attenuated by ANP, and
 .this effect was inhibited by PT pretreatment, consistent with mediation by a Gi protein s . These data indicate that in
addition to the lung being a major clearance organ for circulating ANP, lung parenchymal cells are targets of ANP action.
q 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
 .The alveolar epithelial type 2 T2 cell synthesizes
and secretes pulmonary surfactant, transports ions,
proliferates during repair of the injured lung, and
participates in immune functions and fibrinolysis.
Abbreviations: ANP, atrial natriuretic peptide; PT, pertussis
toxin; CT, cholera toxin
) Corresponding author. Pulmonary and Critical Care, 3C-383,
Houston VA Medical Center, 2002 Holcombe Boulevard, Hous-
ton, TX 77030, USA. Fax: q1-713-794-7853; E-mail:
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Despite the increasing recognition of varied T2 cell
functions, relatively little is known of the regulation
of these processes. The best characterized T2 cell
signal transduction systems relate to the secretion of
 w x.pulmonary surfactant reviewed in Refs. 1–3 . b-
adrenergic agonists, A and P purinoceptor agonists2 2
and histamine all induce surfactant secretion by re-
ceptor-mediated stimulation of adenylyl cyclase. P2
purinoceptor agonists, vasopressin, lipoproteins and
eicosanoids promote surfactant secretion by
receptor-mediated activation of phosphoinositide-
specific phospholipase C or phospholipase D. Mecha-
nisms of inhibition of surfactant secretion by surfac-
0167-4889r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
 .PII S0167-4889 98 00023-8
( )M.P. Panchenko et al.rBiochimica et Biophysica Acta 1403 1998 115–125116
 .tant apoprotein A SPA , plant lectins, A purinocep-1
tor agonists, substance P and compound 48r80 are
less well understood.
Several T2 cell receptors have been shown to
couple positively to adenylyl cyclase via the stimula-
w xtory G-protein, Gs 1–3 . However, to our knowledge
no natural ligand–receptor complex has been demon-
strated to negatively regulate adenylyl cyclase activ-
 .ity via the pertussis toxin PT -sensitive inhibitory
G-protein, Gi. Classically, only receptors of the hep-
tahelical family related to rhodopsin were found to
w xcouple to G-proteins 4,5 . However, there are several
recent examples of G-protein activation by single
membrane-spanning receptors and other non-classical
w xproteins 6–11 , and one of us previously observed
PT-sensitive inhibition by ANP of isoproterenol-
stimulated adenylyl cyclase activity in lung mem-
w xbranes 12 . Three distinct ANP receptors have been
cloned and characterized in some detail: the ANP-A,
ANP-B, and ANP-C receptors reviewed in Refs.
w x.13–16 . The first two of these are transmembrane
 .guanylyl cyclases also known as GC-A and GC-B
which share considerable structural homology. The
third ANP receptor, known as the clearance receptor,
contains a large extracellular ligand binding domain
with homology to the extracellular region of the
ANP-A and ANP-B receptors. It possesses only a
short intracellular domain, and its role in signal trans-
duction is controversial.
The lung is thought to be a major clearance organ
for circulating ANP, but evidence of regulation of the
physiology of pulmonary parenchymal cells by ANP
w xis limited 13,15–19 . In the present study, we find
that ANP attenuates b-adrenergic stimulation of
adenylyl cyclase activity and reduces b-adrenergic-
induced cAMP accumulation in T2 cells. In contrast,
a series of ligands known to interact with heptahelical
receptors that couple negatively to adenylyl cyclase
in other cells had no effect on T2 cells. The effects of
ANP on adenylyl cyclase are shown to be mediated
 .by a PT-sensitive Gi protein s and to correlate with
PT-sensitive inhibition of stimulated T2 cell surfac-
tant secretion. In addition, ANP is found to elevate
the cGMP level of T2 cells through a PT-insensitive
mechanism. These results indicate that ANP activates
multiple signal transduction pathways and modulates
the secretory physiology of T2 pulmonary alveolar
epithelial cells.
2. Materials and methods
2.1. Isolation of lung cells
T2 cells were isolated from adult 6–10 weeks
.postnatal rats from Charles River Laboratories
 . w xWilmington, MA as described 7,20,21 . Briefly,
the lungs were perfused and lavaged with a balanced
salt solution, then porcine pancreatic elastase
 .Worthington, Malvern, PA was instilled via the
trachea. Dispersed cells were collected by filtration
and centrifugation, and partially purified by panning
w xon rat IgG-coated plates 20 . Non-adherent cells,
judged to be 85–90% T2 cells by Papanicolaou stain,
were aspirated from the plates, collected by centrifu-
gation, and either analyzed immediately or cultured
on plastic for subsequent study. Cultured cells were
 .maintained in minimal essential medium MEM that
included vitamins, non-essential amino acids, L-
glutamine, sodium pyruvate, penicillinrstreptomycin,
w xand 10% fetal bovine serum 7 , and incubated with
5% CO in air at 378C. Attachment efficiency was2
about 50%, and the attached cells were )95% T2
cells.
( )2.2. T2 cell treatment with PT or cholera toxin CT
 6 .Cultured T2 cells 2=10 cells per 60 mm dish
were washed with MEM, covered with 3 ml of
MEM, and then CT 1 mgrml, Sigma, St. Louis,
. MO or PT 0.5 mgrml, kindly supplied by Dr. V.O.
Rybin, Laboratory of Molecular Endocrinology, Car-
.diology Research Center of Russia, Moscow, Russia
were added. Cells were incubated for 2 h at 378C,
then washed with MEM, removed from the culture
dish by gentle scraping, and used for the isolation of
crude membranes.
2.3. Preparation of crude membranes from T2 cells
Freshly isolated or cultured T2 cells were sus-
 6 .pended 10 cellsrml in 20–25 ml of cold 20 mM
 .Tris–HCl pH 8.0 at 48C , 1 mM EDTA, 0.1 mM
phenylmethylsulfonyl fluoride, and 5 mgrml leu-
 .peptin all from Sigma . Cells were homogenized
with several strokes of a Dounce homogenizer and
centrifuged for 30 min at 50 000 rpm Ti 70 rotor,
.Beckman, Fullerton, CA . The pellet was resus-
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pended in 5 ml of the same buffer and again cen-
trifuged for 30 min at 50 000 rpm. The second pellet
was resuspended in the same buffer without protease
inhibitors to give a final protein concentration of 1
w xmgrml 22 , frozen in liquid nitrogen, and stored at
y808C.
[ 32 ]2.4. Toxin-catalyzed P ADP-ribosylation
 .The reaction mixture final volume 100 ml con-
 .tained 50 mM Tris–HCl pH 8.0 at 378C , 2 mM
MgCl , 1 mM EDTA, 1 mM ATP, 10 mM dithio-2
 .threitol, 10 mM thymidine all from Sigma , 10 mM
NAD, 1 mM NADP both from Boehringer–Mann-
. w 32 xheim, Indianapolis, IN , 2–3 mCi adenylate- P NAD
 .New England Nuclear, Boston, MA , 0.1 mM
guanine nucleotide where indicated Boehringer-
.Mannheim , and 5–15 mg membrane protein for use
 .with PT 10 mgrml or 50 mg membrane protein for
 .use with CT 50 mgrml . Incubation was carried out
for 60 min at 378C, during which the NAD concentra-
tion remained at 70–90% of the initial level as
determined by cellulose chromatography. The ADP-
ribosylation reaction was stopped by adding Laemmli
sample buffer and boiling for 5 min, and proteins
were separated by SDS-PAGE 12% running and 4%
.stacking gels . After fixation, staining, and drying,
w32 xP ADP-ribosylated proteins were visualized by
autoradiography of gels stored at y708C for 12–16
h.
2.5. Measurement of adenylyl cyclase acti˝ity
 .The reaction mixture final volume 60 ml con-
 .tained 50 mM Tris–HCl pH 7.5 at 378C , 120 mM
NaCl, 1 mM cAMP, 10 mM creatine phosphate, 0.5
 .mM isobutyl-1-methylxanthine IBMX , 5 mM
 .MgCl , 1 mM dithiotreitol all from Sigma , 0.1 mM2
ATP, 0.25 mgrml creatine kinase both from
. w 32 x Boehringer-Mannheim , 2 mCi a- P ATP 3000
.Cirmmol, Amersham, Arlington Heights, IL and
10–15 mg membrane protein. Membranes were incu-
 .bated with ligands all from Sigma known to influ-
ence the activity of adenylyl cyclases in other sys-
tems, with or without ANP rat ANF 99–126, a-
.rANP, Penisula Laboratories, Belmont, CA , for 378C
for 10–20 min. Under these assay conditions, activity
was linear with time and the ATP concentration was
maintained at 95% of the initial level as determined
by polyethyleneimine-cellulose chromatography. The
reaction was terminated by adding 200 ml 0.5 M HCl
followed by immersion in boiling water for 7 min.
Samples were neutralized by adding 200 ml 1.5 M
imidazole, and cAMP levels were determined by the
w xmethod of White 23 .
2.6. Immunoblotting
Proteins separated by SDS-PAGE were electroblot-
 .ted 14 h, 48C, 300 mA onto nitrocellulose paper
 .0.2 mm pore size . Nitrocellulose strips were then
incubated with anti-Gsa-common antiserum 1:1000
.  .dilution , anti-Gia-common 1:1000 , anti-Gi a1
 .  .  .1:10 , anti-Gia 1:500 , anti-Gia 1:500 , or anti-2 3
 .  .Goa-common 1:500 , in 50 mM Tris–HCl pH 7.4 ,
200 mM NaCl, 3% bovine serum albumin and 0.2%
Nonidet P-40 for 2 h at room temperature. Im-
w125 xmunoreactive proteins were visualized using I -
 .labelled donkey anti-rabbit IgG Amersham fol-
lowed by autoradiography. Antiserum to Gia was a1
gift of Dr. J.M. Stadel SmithKline Beecham,
.Philadelphia, PA , and antisera to Gia-common
 .  .  .aA9 , Gia aA56 , Gia aA54 , Goa-common2 3
 .  .aA10 , and Gsa-common a584 were kindly pro-
vided by Dr. J.D. Robishaw Weis Research Center,
.Geisinger Clinic, Danville, PA .
2.7. Measurement of intracellular cyclic nucleotide
le˝els
Cultured T2 cells at 2–2.5=105 cellsrwell for
cAMP determination and 5–10=105 cellsrwell for
cGMP determination were preincubated with or with-
 .  .out PT 0.5 mgrml or CT 1 mgrml for 2 h.
Following preincubation, cells were washed with
MEM and incubated in 0.5–1 ml MEM containing
0.5 mM IBMX for 30 min. Isoproterenol andror
ANP were then added and cells were further incu-
bated for 5 min at 378C. This time was chosen based
on work in other systems showing maximal and
stable ligand-induced elevation of cyclic nucleotides
in the presence of the phosphodiesterase inhibitor
w xIBMX 12,24,25 , and differs from the transient ele-
vation in nucleotide levels observed in T2 cells when
w xmeasured in the absence of IBMX 26 . The reaction
was stopped by removing medium and adding 0.5–1
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Table 1
Modulation of adenylyl cyclase by ANP
Control ISO PGE FORSKOL1
Control 8.43"0.43 33.58"0.72 20.23"0.89 201.17"6.25
ANP 8.12"0.68 22.35"0.57) 14.77"0.69) 141.67"3.53)
GDPb S 6.35"0.50 6.83"0.59 6.80"0.63 123.67"4.58
ANPqGDPb S 7.05"0.42 7.07"0.58 7.13"0.78 135.67"6.41
T2 cell membranes were assayed for adenylyl cyclase activity in the presence of 10 mM GTP, and some assays additionally contained
100 mM GDPb S.
Values represent adenylyl cyclase activity expressed as pmol cAMP miny1 mg proteiny1, and are the mean"SEM of six data points
pooled from two experiments.
 .Asterisks denote significant differences pF0.0001 between membranes exposed and membranes not exposed to 5 mM ANP.
ISOs50 mM isoproterenol, PGE s10 mM, FORSKOLs10 mM forskolin.1
 .ml of hot acidic ethanol:water 2:1 solution to each
well. Cell lysates were transferred into glass tubes
 .12=75 mm and centrifuged at 5000=g for 10
min. Supernatants were collected and pellets ex-
tracted again in the same way. Supernatants from the
first and second centrifugations were combined and
evaporated in a nitrogen stream at 608C. Dry residues
were dissolved in 100 ml Tris–EDTA buffer, and
cAMP or cGMP were measured using assay kits
according to the manufacturer’s protocols
 .Amersham .
2.8. Phosphatidylcholine secretion
 6 .T2 cells 10 rml were plated in 16 mm wells
containing 500 m l medium and 1 mCirml
w3 xH choline, and allowed to incubate for 18 h at 378C.
During the last 2 h of metabolic labelling, 0.5 mgrml
PT was added to some wells. Cells were then gently
washed three times with MEM containing 100 mM
 .pyruvate, 40 mM HEPES pH 7.4 , and 3 mgrml
bovine serum albumin, with or without 100 mM
isoproterenol andror varying concentrations of ANP.
w3 xAfter 3 h incubation at 378C, H phosphatidylcholine
secretion was measured by scintillation counting of
dried organic extracts of the media and cells as
w xpreviously described 7 . Secretion was calculated as
the ratio of counts in the medium of each well to the
sum of the counts in the medium and cell layer of
that well.
2.9. Statistical methods
Two-tailed Student’s t-test was used for compari-
 .son between experimental groups Tables 1 and 2 ,
and Dunnett’s test was used for comparison of muti-
Table 2
Modulation by PT and CT of ANP’s effect on adenylyl cyclase
Control ISO FORSKOL
Not pretreated Control 10.82"0.45 45.33"1.38 248.67"5.06
ANP 10.55"0.78 32.06"0.85) 183.33"3.45)
CT-pretreated Control 55.73"0.5 67.98"2.14 583.83"12.19
ANP 44.35"0.95) 47.97"1.12) 412.50"5.57)
PT-pretreated Control 18.80"0.88 60.72"1.76 370.33"7.34
ANP 18.45"0.93 57.05"1.56 374.67"10.01
T2 cells were preincubated with or without CT or PT for 2 h, followed by isolation of membranes and assay for adenylyl cyclase activity
as in Table 1.
Values represent adenylyl cyclase activity expressed as pmol cAMP miny1 mg proteiny1, and are the mean"SEM of six data points
pooled from two experiments.
 .Asterisks pF0.0001 denote significant differences between membranes exposed and membranes not exposed to 5 mM ANP.
Abbreviations are as in Table 1.
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Fig. 1. Dose-dependent reduction of adenylyl cyclase activity by
ANP. Membranes from T2 cells were assayed for adenylyl
cyclase activity in the presence of 10 mM GTP, 10 mM forskolin
and varying concentrations of ANP. Values are the mean"SEM
of six data points pooled from two experiments.
ple experimental groups against a single control Fig.
.6 . Analysis of variance of the data indicated that the
effects of separate experiments, separate measure-
ments within an experiment, and the interaction be-
tween exposure to ANP and experiments were mini-
mal compared to exposure to ANP, so these three
effects were pooled and serve as the source of ran-
dom variation in assessing the effect of exposure to
ANP. Results should be generalized to the population
with some caution in view of the small number of
experimental subjects. Computations were performed
using the computer program SYSTAT Evanston,
.IL . Dose–response curves were fitted by the pro-
 .gram SigmaPlot San Rafael, CA using the four
 .  .parameter logistic equation: f x sdq ayd r1q
 .bxrc , where as the upper asymptote, bs the
slope, cs the inflection point equivalent to the
.EC , and ds the lower asymptote.50
3. Results
3.1. ANP attenuates the ligand-stimulated adenylyl
cyclase acti˝ity of T2 cell membranes
The activity of adenylyl cyclase in membranes
isolated from rat T2 cells was stimulated 2.4, 4 and
24-fold by PGE , isoproterenol, and forskolin, re-1
 .spectively Table 1 . The b-adrenergic specificity of
isoproterenol was confirmed by the ability of the
b-adrenergic antagonists propranolol and alprenolol,
but not the a -adrenergic antagonist prazosin or the1
 .a -adrenergic antagonist yohimbine 10 mM each ,2
 .to abolish adenylyl cyclase stimulation not shown .
 .ANP 5 mM induced an approximately 30% de-
crease in adenylyl cyclase activity stimulated by
w32 xFig. 2. P ADP-ribosylation of T2 cell membrane G-protein a subunits catalyzed by CT and PT. Shown are autoradiograms of
w32 xmembrane proteins P ADP-ribosylated in the presence or absence of bacterial toxins and separated by SDS-PAGE. The indicated
 .guanine nucleotides were added to the membranes for 15 min at 378C prior to addition of the rest of the reaction mixture. A Each lane
 .  .contains 50 mg of membrane protein, and all lanes except the first were treated with CT 50 mgrml . B Each lane contains 15 mg of
 .membrane protein, and all lanes except the first were treated with PT 10 mgrml .
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 .Fig. 3. Immunochemical identification of G-protein a subunits in T2 cell membranes. Western-blotted T2 cell membranes 50 mg were
 .  . incubated with antisera with specificity for all Gia subunits left lane , individual Gia species next three lanes , Goa subunits second
.  . 125from right lane , or Gsa subunits right lane . The immunoblots were developed with I-labelled secondary antibodies, and
autoradiograms are shown.
PGE , isoproterenol, or forskolin, although it did not1
 .significantly alter basal enzyme activity Table 1 .
The EC for ANP-induced inhibition of forskolin-50
stimulated adenylyl cyclase activity was 91 nM Fig.
.1 . Ligands known to inhibit stimulated adenylyl
cyclase activity in other cell types 50 mM histamine,
10 mM PGE , 50 mM serotonin, 10 mM somato-2
statin, 50 mM carbamylcholine, or 10 mM substance
.P did not affect basal, isoproterenol- or forskolin-
stimulated adenylyl cyclase activities in T2 mem-
 .branes not shown .
3.2. ANP attenuation of ligand-stimulated adenylyl
cyclase acti˝ity is mediated by a PT-sensiti˝e Gi2( )andror Gi protein s3
As expected for ligands whose activation of adeny-
lyl cyclase activity proceeds via the stimulatory G-
w xprotein, Gs 4,5 , the activation of adenylyl cyclase
by PGE or isoproterenol was abrogated by addition1
of the metabolically stable GDP analogue, GDPb S
 .Table 1 . Stimulation of adenylyl cyclase by
forskolin, which is due to a combination of direct
interaction with adenylyl cyclase and activation of Gs
w x  .27 , was less sensitive to GDPb S Table 1 . The
presence in T2 cell membranes of both the lower 42
.  .kDa and higher 50 kDa molecular mass forms of
Gsa subunits was demonstrated by CT-catalyzed
w32 xP ADP-ribosylation in the presence of GTP or
 .stable GTP analogs Fig. 2A . This result was con-
firmed by immunoblotting with anti-Gsa antiserum
 .Fig. 3 .
ANP failed to attenuate forskolin-stimulated
adenylyl cyclase activity in the presence of GDPb S
 .Table 1 , suggesting that ANP also modulates adeny-
lyl cyclase activity via a G-protein. To explore this
hypothesis, T2 cells were treated with CT or PT to
allow the ADP-ribosylation of cognate G-proteins.
The cells were then lysed and their membranes as-
sayed for the modulation of adenylyl cyclase activity
 .by stimulatory ligands and ANP Table 2 . In mem-
branes isolated from CT-pretreated cells, basal adeny-
w32 xFig. 4. Toxin-catalyzed P ADP-ribosylation of G-proteins in membranes from T2 cells previously exposed to CT or PT. Plated T2 cells
 .  .were incubated with or without CT 1 mgrml or PT 0.5 mgrml for 2 h at 378C. Cells were then lysed and their membranes subjected
w32 x  .to P ADP-ribosylation catalyzed by either toxin in the presence of GTP as in Fig. 2. A Membranes from control cells not exposed to
 .  .toxins. B Membranes from cells pretreated with CT. C Membranes from cells pretreated with PT.
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lyl cyclase activity increased five-fold, and further
stimulation by ligands was reduced. Nonetheless,
ANP attenuated isoproterenol- and forskolin-stimu-
lated adenylyl cyclase activities by 29% each and
‘basal’ activity by 20%. In contrast, pretreatment
with PT effectively eliminated the effect of ANP on
ligand-stimulated adenylyl cyclase activity, although
 .it increased basal activity 74% Table 2 . The speci-
ficity and completeness of ADP-ribosylation of G-
protein a subunits was assessed in Fig. 4. The
exposure of intact T2 cells to CT prevented the
w32 xsubsequent CT-catalyzed transfer of P ADP-ribose
to 42 and 50 kDa Gsa subunits in membranes
isolated from these cells, but not the PT-catalyzed
w32 xP ADP-ribosylation of 40–41 kDa Gia subunits
 .Fig. 4B . Similar specificity and efficiency was
demonstrated for PT-dependent ADP-ribosylation of
 .Gia subunits in intact cells Fig. 4C .
The ADP-ribosylation of 40 and 41 kDa substrates
catalyzed by PT did not require added guanine nu-
cleotides and was slightly reduced by the presence of
the metabolically stable GTP analog, GTPg S Fig.
.2B , in contrast to the obligatory dependence on
triphosphoguanine nucleosides for CT-catalyzed
 .ADP-ribosylation of Gsa Fig. 2A . This is consis-
tent with the described behavior of Gi or Go proteins
w xas substrates for PT-catalyzed ADP-ribosylation 28 .
Specific antisera against known PT-sensitive G-pro-
 .tein a subunits identified Gia 40 kDa and Gia2 3
 .41 kDa , but not Gia or Goa , in T2 membranes1
 .Fig. 3 . Northern blot analysis also revealed the
presence of Gia and Gia , but not Gia or Goa ,2 3 1
 .mRNA in T2 cells not shown .
3.3. ANP decreases the cAMP le˝el and increases the
cGMP le˝el of T2 cells
Increasing the ANP concentration in the medium
from 10y10 to 10y5 M produced a dose-dependent
40% decrease in the cAMP level of isoproterenol-
stimulated T2 cells with an EC of 8.6 nM Fig.50
.5A . Treatment of T2 cells with PT for 2 h and
IBMX for 30 min resulted in an approximately two-
fold elevation of intracellular cAMP from 3.6"0.2
6  .to 7.4"0.5 pmolr10 cells not shown . However,
further exposure to 50 mM isoproterenol for 5 min
raised the cAMP in PT-treated cells 216 " 2
6 . pmolr10 cells and untreated cells 214 " 4
Fig. 5. Effect of ANP on T2 cell cAMP and cGMP levels.
Following pretreatment with or without 0.5 mgrml PT for 2 h
and with 500 mM IBMX for 30 min, increasing concentrations of
ANP were added along with 50 mM isoproterenol to cultured T2
cells. Cyclic nucleotides were allowed to accumulate for 5 min
and levels were then measured by radioimmunoassay. Values are
the mean"SEM of six data points pooled from two experiments.
Circles: cells not exposed to PT; squares: cells exposed to PT.
 .  .A cAMP levels. B cGMP levels.
6 .  .pmolr10 cells to indistinguishable levels Fig. 5A ,
so the effect of PT on ANP exposure could be readily
assessed. PT-pretreatment prevented the inhibition of
isoproterenol-stimulated cAMP accumulation by ANP
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 .Fig. 5A , consistent with the findings in T2 cell
 .membranes Table 2 . Over the same concentration
range, ANP produced an 11.4-fold increase in the
 .cGMP level, with an EC of 22 nM Fig. 5B . There50
was no effect of pretreatment with PT on the basal
cGMP level or on ANP-dependent cGMP accumula-
 .tion in T2 cells Fig. 5B .
3.4. ANP decreases isoproterenol-stimulated T2 cell
phosphatidylcholine secretion
Phosphatidylcholine is the most abundant compo-
w xnent of pulmonary surfactant 1–3 , and its release
from cultured T2 cells was measured to assess the
effect of ANP on surfactant secretion. There was no
measurable effect of 10y8 to 10y6 M ANP on consti-
w3 x  .tutive H phosphatidylcholine secretion not shown .
However, in preliminary experiments, ANP was ob-
w3 xserved to inhibit H phosphatidylcholine secretion in
those T2 cell isolates in which isoproterenol induced
a robust increase in secretion. We therefore analyzed
the effect of ANP only in isolates with isoproterenol-
induced secretion greater than 200% above unstimu-
Fig. 6. Effect of ANP on phosphatidylcholine secretion. Plated
w3 xT2 cells were metabolically labeled with H choline, pretreated
with or without 0.5 mgrml PT for 2 h, then stimulated to secrete
 .for 3 h with 100 mM isoproterenol ISO in the presence of
varying concentrations of ANP. Values are the mean"SEM of
12 data points pooled from three experiments. Asterisks denote
 .significant differences p-0.0001 between cells exposed and
cells not exposed to ANP in presence of ISO.
lated. Of 10 T2 cell isolates, three met this criterion,
and their response to ANP is depicted in Fig. 6; of
the remaining seven isolates, secretion was stimulated
0–50% by isoproterenol in four with no measurable
effect of ANP, while in three isolates secretion was
stimulated 50–200% by isoproterenol with a mean
 .22% inhibition by 1 mM ANP data not shown . Fig.
6 illustrates that in T2 cells with the most robust
secretory response to isoproteronol, ANP caused a
w3 xdose-dependent attenuation of H phosphatidylcho-
line secretion, with 66% inhibition induced by 1 mM
ANP. Pretreatment of T2 cells with PT impaired the
inhibitory effect of ANP on isoproterenol-stimulated
 .secretion Fig. 6 .
4. Discussion
We have found that exposure of intact T2 cells to
ANP results in a marked attenuation of ligand-stimu-
 .lated cAMP accumulation Fig. 5A . A previous study
of bovine granulosa cells implicated the activation of
a cGMP-dependent phosphodiesterase in the reduc-
w xtion by ANP of ACTH-stimulated cAMP levels 29 .
This is unlikely to be the principal mechanism in T2
cells because ANP also inhibited adenylyl cyclase
activity in a washed particulate fraction Table 1 and
.Fig. 1 , suggesting a membrane-delimited mechanism
not involving soluble second messengers or proteins.
Also, IBMX, a potent inhibitor of cGMP-activated
phophodiesterase, was present in our experiments
 .Table 1, Figs. 1 and 5A , and ANP-induced de-
 .creases in adenylyl cyclase activity Table 2 and
 .cAMP levels Fig. 5A were blocked by PT even
though PT had no effect on ANP-stimulated cGMP
 .accumulation Fig. 5B . Instead, the inhibition of
ligand-stimulated but not basal adenylyl cyclase ac-
tivity by ANP and the elimination of this effect by a
 .stable GDP analog Table 1 suggest that ANP modu-
lates adenylyl cyclase activity in T2 cells primarily
 .via receptor activation of a G-protein s . This inter-
pretation is supported by the fact that pretreatment
with PT prevents the effect of ANP on ligand-stimu-
 .lated adenylyl cyclase activity Table 2 and cAMP
 . w32 xaccumulation Fig. 5A . PT-dependent P ADP-
 w x.ribose radiolabeling studies Fig. 2 and Ref. 30 and
 .Western blot analysis Fig. 3 indicate that T2 cells
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contain the PT substrates Gi and Gi , either or both2 3
of which might transduce this signal. The molecular
mechanisms of Gi-mediated inhibition of adenylyl
cyclases include direct interaction of Gia subunits
with some adenylyl cyclase isoforms, sequestration of
Gsa subunits by Gibrg subunits following Gi trimer
activation, and direct interaction of Gibrg subunits
with some adenylyl cyclase isoforms reviewed in
w x.Refs. 4,5,27 . The molecular identities of adenylyl
cyclase isoforms expressed in T2 cells are currently
unknown, and the nature of their interactions with Gi
w xproteins has only recently begun to be explored 7,31 .
Gi-mediated inhibition of adenylyl cyclase activity
by ANP has been previously reported in several
 w x.different cell types reviewed in Refs. 13,15,16 .
Based on the use of receptor subtype-selective ANP
analogs, it has been proposed that G-protein-depen-
dent modulation of adenylyl cyclase and phospholi-
pase activities occurs as a result of ANP binding to
the ANP-C receptor. The deduced amino acid struc-
ture of the ANP-C receptor predicts a single mem-
brane-spanning segment with a short intracytoplasmic
domain. Analysis of the single membrane-spanning
IGF-IIrmannose 6-phosphate receptor has defined a
polybasic segment of the intracytoplasmic domain
w xthat is directly involved in G-protein coupling 9 .
This is reminiscent of a polybasic segment of the
signal-transducing third cytoplasmic loop of many
heptahelical receptors, and suggests a common mech-
anism for G-protein coupling to seven membrane-
spanning and single membrane-spanning receptors.
The ANP-C receptor meets the structural require-
ments for G-protein coupling defined for the IGF-II
receptor of two basic amino acids followed by a
B–B–B–X–X–B motif in which B is a basic amino
w xacid and X is non-basic 15 . Further, a peptide
corresponding to the cytoplasmic domain of the
ANP-C receptor inhibits adenylyl cyclase in a PT-
sensitive manner, and antibodies to this domain dis-
w xrupt the effect of ANP an adenylyl cyclase 32 .
Consistent with the reduction by ANP of isoprote-
renol-stimulated cAMP levels in T2 cells, ANP sub-
stantially reduced isoproterenol-stimulated phos-
 .phatidylcholine secretion Fig. 6 . The somewhat
 .greater efficacy of ANP in reducing secretion Fig. 6
 .than in reducing adenylyl cyclase activity Table 1
 .and cAMP levels Fig. 5A may reflect less cAMP
accumulation in the secretion study which lacked a
phosphodiesterase inhibitor, a non-linear relationship
between cAMP levels and secretion in T2 cells, or
participation of an additional second messenger. ANP
similarly inhibits secretion from diverse endocrine
 w x.and non-endocrine cells reviewed in Ref. 13 . The
reported mechanisms include cGMP-dependent phos-
phodiesterase activation, G-protein mediated inhibi-
tion of adenylyl cyclase, modulation of ion conduc-
tances, and inhibition of phospholipase activities.
 .Since our cAMP accumulation study Fig. 5A was
performed in the presence of a phosphodiesterase
inhibitor and we did not independently examine
phosphodiesterase activation as a mechanism for re-
ducing cAMP levels, we cannot strictly rule out a
dual mechanism Gi activation and phosphodiesterase
.activation mediating ANP-induced reductions in
cAMP and surfactant secretion. However, the inhibi-
tion by PT pretreatment of ANP’s effect on phos-
 .phatidylcholine secretion Fig. 6 indicates that the
major pathway in T2 cells is via activation of a Gi
protein. The lack of effect of ANP on basal surfactant
secretion in our study is at variance with a previous
morphologic analysis that suggested that ANP pro-
w xmotes surfactant secretion 33 .
The effect of ANP in increasing intracellular cGMP
 .Fig. 5B suggests that rat T2 cells likely contain one
or both of the known ANP receptors which possess
w xintrinsic guanylyl cyclase activity 14 . Our finding is
consistent with the recent identification of an ANP-
stimulated particulate guanylyl cyclase in T2 cells by
w xcytochemical techniques 18 . Although both the
ANP-A and ANP-B receptors are able to respond to
ANP, the ANP-B receptor shows a much higher
affinity for CNP central nervous system natriuretic
.peptide than for ANP and is predominantly ex-
w xpressed in the brain 14,16 . Concentrations of ANP
effective in elevating T2 cGMP levels EC s2250
.nM, Fig. 5B are similar to those reported in other
mammalian systems signalling via the ANP-A recep-
tor and are several orders of magnitude lower than
w xthose effective at the rat ANP-B receptor 34 . There-
fore, it is likely that ANP elevates cGMP in rat
alveolar T2 cells via the ANP-A receptor. The role of
elevated cGMP in regulating T2 cell physiology is
not yet known.
ANP has the potential of regulating important T2
cell functions beside surfactant secretion. Transport
of ions, maintenance of a permeability barrier, and
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cellular proliferation are important T2 cell functions
that are modulated by ANP in other cell types
w x13,15,16,18 . The source of ANP in T2 cell regula-
tion also remains unexplored. The fact that circulat-
ing ANP levels are in the range of 20 pM whereas
the biochemical effects we measured occur with EC50
values of 8–22 nM suggest that paracrine or au-
tocrine signalling might be most important. Of inter-
est, ANP peptide and prohormone and ANP mRNA
w xhave been found in lung epithelium 18 . A full
appreciation of the role of ANP as a regulator of T2
cell physiology will depend on further elucidation of
extracellular and intracellular ANP signalling path-
ways and the examination of multiple possible effec-
tor functions.
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